Zobrazeno 1 - 3
of 3
pro vyhledávání: '"G. Dozias"'
Publikováno v:
Section 3: Production and Compounding.
Background In our medical centre, the production of injectable ant-ineoplastic rose 20% between 2015 and 2017. As a consequence, the dispensing delay increased. It has therefore been decided to implement dose-banding. In order to guarantee the steril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1b2b79a1ef56484e3f678a68f4c0386
https://doi.org/10.1136/ejhpharm-2019-eahpconf.103
https://doi.org/10.1136/ejhpharm-2019-eahpconf.103
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The development and expansion of oral anti-cancer agents provide multiple benefits, including improvement in patients’ quality of life but also create numerous challenges such as side-effect management or medication adherence. In January
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::779a0c6ea0a23c0b8d8ac36d8d05141b
https://doi.org/10.1136/ejhpharm-2019-eahpconf.408
https://doi.org/10.1136/ejhpharm-2019-eahpconf.408
Autor:
L. Khatchatourian, N. Saidani, G. Dozias, C. Partant, M. Harry, J. Talarmin, T. Briand, L. Guillemette
Publikováno v:
Médecine et Maladies Infectieuses. 49:S52
Introduction La prise en charge des IOA est complexe et associe chirurgie, une antibiotherapie combinant plusieurs molecules, a posologies adaptees et au long cours. A la sortie d’hospitalisation, le risque d’indisponibilite du medicament (pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f57c5ba88b38672d960d1620286e3473
https://doi.org/10.1016/j.medmal.2019.04.133
https://doi.org/10.1016/j.medmal.2019.04.133